Last reviewed · How we verify

NCT05768594: OVERLOAD

Omics in Valvular Disease

Status unknown Last updated 20 March 2023
What this trial tests

trial testing Blood sample in Stenosis, Aortic in 30 participants. Status unknown.

Timeline
15 November 2019
Primary endpoint
5 November 2020
13 December 2023

Quick facts

Lead sponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date15 November 2019
Primary completion5 November 2020
Estimated completion13 December 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Who can join

Adults 45 to 80, any sex, with Stenosis, Aortic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of our study is to investigate the effects of impaired left ventricular remodeling on the short- and long-term prognosis in AS partecipants undergoing extracorporeal circulation during valve repair surgery and in partecipants undergoing implantation transcatheter. For the achievement of these purposes, markers obtained from will be considered cardiovascular imaging methods, such as color Doppler echocardiography and isolated biomarkers from peripheral blood and heart tissue.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Blood sample

Trials testing the same drug.

Other Fondazione Policlinico Universitario Agostino Gemelli IRCCS trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05768594.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing